Stimulation of postsynaptic D2− dopamine receptors by B‐HT 958 is revealed by co‐treatment with the D1− receptor agonist SKF 38393
暂无分享,去创建一个
[1] N. Andén,et al. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors. , 1988, Acta physiologica Scandinavica.
[2] F. Ferrari,et al. Imidazole and yohimbine antagonize hypomotility, penile erection, stretching and yawning induced in rats by BHT 920, a selective dopamine autoreceptor agonist. , 1988, Pharmacological research communications.
[3] O. Hornykiewicz,et al. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. , 1988, European journal of pharmacology.
[4] F. J. White,et al. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. , 1988, Life sciences.
[5] N. Andén,et al. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors. , 1987, Acta physiologica Scandinavica.
[6] N. Andén,et al. Inhibitory role of D‐1 dopamine receptors for the jerks induced by B‐HT 920 in rats , 1987, The Journal of pharmacy and pharmacology.
[7] J. Hyttel,et al. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. , 1987, European journal of pharmacology.
[8] F. J. White,et al. Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications , 1987 .
[9] T. Chase,et al. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. , 1986, European journal of pharmacology.
[10] O. Hornykiewicz,et al. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. , 1986, European journal of pharmacology.
[11] J. Waddington. Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems. , 1986, Biochemical pharmacology.
[12] O. Hornykiewicz,et al. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain. , 1984, European journal of pharmacology.
[13] N. Andén,et al. B‐HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain , 1984, The Journal of pharmacy and pharmacology.
[14] N. Andén,et al. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. , 2009, Acta pharmacologica et toxicologica.
[15] L. Pichler,et al. Investigation into different types of post- and presynaptic alpha-adrenoceptors at cardiovascular sites in rats. , 1980, European journal of pharmacology.
[16] T. Svensson,et al. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. , 1974, Brain research.